Developer of oncolytic viruses designed to treat cancer. The company's oncolytic viruses are developed with improved therapeutic amplification at the tumor site and has the ability to survive in the body's circulation to target tumor metastases, which are the main cause of morbidity and mortality, enabling patients to begin treatment more quickly, resulting in a higher likelihood of a more successful tumor treatment.